| Product NDC: | 16590-423 |
| Proprietary Name: | LOPERAMIDE HYDROCHLORIDE |
| Non Proprietary Name: | LOPERAMIDE HYDROCHLORIDE |
| Active Ingredient(s): | 2 mg/1 & nbsp; LOPERAMIDE HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16590-423 |
| Labeler Name: | STAT Rx USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA073192 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19930501 |
| Package NDC: | 16590-423-20 |
| Package Description: | 20 CAPSULE in 1 BOTTLE (16590-423-20) |
| NDC Code | 16590-423-20 |
| Proprietary Name | LOPERAMIDE HYDROCHLORIDE |
| Package Description | 20 CAPSULE in 1 BOTTLE (16590-423-20) |
| Product NDC | 16590-423 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LOPERAMIDE HYDROCHLORIDE |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19930501 |
| Marketing Category Name | ANDA |
| Labeler Name | STAT Rx USA LLC |
| Substance Name | LOPERAMIDE HYDROCHLORIDE |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Opioid Agonist [EPC],Opioid Agonists [MoA] |